This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Human Coagulation Factor VIII
China Biologic Products, Inc.
Drug Names(s): FVIII
FVIII is a plasma product developed from Human Coagulation Factor VIII. FVIII, in combination with FVIX, activates FX in the coagulation cascade.
Human Coagulation Factor VIII News
Pink Sheet FDA Performance Tracker: CBER Approvals
Additional information available to subscribers only: